bf/NASDAQ:ANTX_icon.jpeg

COM:AN2THERAPEUTICS

AN2 Therapeutics

  • Stock

USD

Last Close

1.23

22/11 21:00

Market Cap

77.56M

Beta: -

Volume Today

1.25M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '21
Jun '21
Sep '21
Dec '21
Mar '22
Jun '22
Sep '22
Dec '22
Mar '23
Jun '23
Sep '23
Dec '23
Mar '24
Jun '24
Sep '24
revenue
cost of revenue
gross profit
selling and marketing expenses
general and administrative expenses
401K
-
898K
123.94%
1.59M
76.73%
1.78M
12.29%
2.05M
15.04%
3.63M
77.32%
3.34M
8.06%
3.72M
11.43%
4.05M
8.86%
3.06M
24.44%
3.75M
22.46%
3.64M
-
3.73M
2.47%
3.48M
6.62%
selling general and administrative expenses
401K
-
898K
123.94%
1.59M
76.73%
1.78M
12.29%
2.05M
15.04%
3.63M
77.32%
3.34M
8.06%
3.72M
11.43%
4.05M
8.86%
3.06M
24.44%
3.75M
22.46%
3.90M
3.87%
3.64M
6.55%
3.73M
2.47%
3.48M
6.62%
research and development expenses
1.65M
-
4.10M
148.64%
5.34M
30.37%
5.81M
8.74%
5.63M
3.08%
6.70M
18.91%
8.43M
25.83%
8.75M
3.84%
11.98M
36.94%
13.54M
12.96%
14.43M
6.58%
14.92M
3.40%
14.65M
1.77%
12.15M
17.10%
8.29M
31.79%
other expenses
-24K
-
-36K
50%
22K
161.11%
1K
95.45%
-15K
1,600%
-35K
133.33%
4K
111.43%
716K
17,800%
797K
11.31%
1.47M
84.82%
2.24M
-
cost and expenses
2.05M
-
5.00M
143.80%
6.93M
38.70%
7.59M
9.55%
7.68M
1.17%
10.33M
34.49%
11.77M
13.91%
12.48M
6.00%
16.04M
28.56%
16.60M
3.50%
18.18M
9.51%
18.82M
3.49%
18.30M
2.76%
15.88M
13.21%
operating expenses
2.05M
-
5.00M
143.80%
6.93M
38.70%
7.59M
9.55%
7.68M
1.17%
10.33M
34.49%
11.77M
13.91%
12.48M
6.00%
16.04M
28.56%
16.60M
3.50%
18.18M
9.51%
18.82M
3.49%
18.30M
2.76%
15.88M
13.21%
14.01M
11.75%
interest expense
2K
-
15K
650%
25K
66.67%
27K
-
228K
744.44%
-431K
289.04%
945K
319.26%
-716K
175.77%
ebitda
-2.05M
-
-5.00M
143.80%
-6.93M
38.70%
-7.59M
9.55%
-7.68M
1.17%
-10.33M
34.49%
-11.77M
13.91%
-12.48M
6.00%
-16.04M
28.56%
-16.60M
3.50%
-18.18M
9.51%
-18.82M
3.49%
-18.30M
2.76%
-15.88M
13.21%
-14.01M
11.75%
operating income
-2.05M
-
-5.00M
143.80%
-6.93M
38.70%
-7.59M
9.55%
-7.63M
0.45%
-10.33M
35.46%
-11.77M
13.91%
-12.48M
6.00%
-16.04M
28.56%
-16.60M
3.50%
-18.18M
9.51%
-18.82M
3.49%
-18.30M
2.76%
-15.88M
13.21%
-14.01M
11.75%
depreciation and amortization
-55K
-
-927K
-
total other income expenses net
2K
-
-24K
1,300%
-36K
50%
22K
161.11%
-27K
222.73%
213K
888.89%
431K
102.35%
634K
47.10%
716K
12.93%
797K
11.31%
1.47M
84.82%
1.92M
30.14%
1.68M
12.42%
1.45M
13.94%
1.27M
12.32%
income before tax
-2.05M
-
-5.01M
144.48%
-6.94M
38.67%
-7.54M
8.67%
-7.66M
1.46%
-10.12M
32.20%
-11.34M
12.05%
-11.84M
4.44%
-15.32M
29.40%
-15.80M
3.14%
-16.71M
5.71%
-16.90M
1.14%
-16.62M
1.66%
-14.44M
13.13%
-12.75M
11.69%
income tax expense
-55K
-
-441K
701.82%
-431K
2.27%
945K
319.26%
-716K
175.77%
net income
-2.05M
-
-5.01M
144.48%
-6.94M
38.67%
-7.54M
8.67%
-7.60M
0.73%
-9.68M
27.36%
-10.91M
12.70%
-12.79M
17.23%
-14.61M
14.23%
-15.80M
8.19%
-16.71M
5.71%
-16.90M
1.14%
-16.62M
1.66%
-14.44M
13.13%
-12.75M
11.69%
weighted average shs out
14.05M
-
14.05M
0%
14.05M
0%
3.18M
-
19.26M
505.46%
19.35M
0.46%
19.35M
0.03%
19.39M
0.17%
19.50M
0.58%
25.65M
31.53%
29.74M
15.95%
29.76M
0.09%
29.82M
0.21%
29.84M
0.06%
weighted average shs out dil
14.05M
-
14.05M
0%
14.05M
0%
3.18M
-
19.26M
505.46%
19.35M
0.46%
19.35M
0.03%
19.39M
0.17%
19.50M
0.58%
25.65M
31.53%
29.74M
15.95%
29.76M
0.09%
29.82M
0.21%
29.84M
0.06%
eps
-0.15
-
-0.36
140%
-0.49
36.11%
0
100%
-2.39
Infinity%
-0.50
79.08%
-0.56
12.00%
-0.66
17.86%
-0.75
13.64%
-0.81
8.00%
-0.65
19.75%
-0.57
12.31%
-0.56
1.75%
-0.48
14.29%
-0.43
10.42%
epsdiluted
-0.15
-
-0.36
140%
-0.49
36.11%
0
100%
-2.39
Infinity%
-0.50
79.08%
-0.56
12.00%
-0.66
17.86%
-0.75
13.64%
-0.81
8.00%
-0.65
19.75%
-0.57
12.31%
-0.56
1.75%
-0.48
14.29%
-0.43
10.42%

All numbers in USD (except ratios and percentages)